1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy
| Autor: | Cho, B.C., Aguado de la Rosa, C., Vilà, L., Isla, D., Oliveira, J., de Castro Carpeno, J., Tomova, A., Kim, T.M., Cordellat, A. Blasco, Bauchet, A-L., Soufflet, C., Bensfia, S., Dy, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1034-S1035 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|